Hedia

Hedia is a digital therapeutics company focused on diabetes management. Its mission is to enhance the quality of life for individuals with diabetes through advanced, personalized management tools. The company has developed the Hedia Diabetes Assistant (HDA), a Class IIb medical device that supports self-management for those with insulin-requiring diabetes, including both Type 1 and Type 2. The Hedia Diabetes Assistant provides personalized insulin dosing recommendations based on user data such as blood glucose levels, carbohydrate intake, and physical activity. This app aims to improve blood glucose stability and overall health outcomes. Hedia collaborates with healthcare professionals and various partners in the diabetes ecosystem, including clinics and device manufacturers, to ensure the product meets real-world needs and regulatory standards. The HDA is available in multiple European countries through healthcare professionals, emphasizing a clinical partnership model. Hedia is also dedicated to ongoing research and clinical studies to validate the effectiveness of its solutions.

• Employees 31
• Founded 2016
• Total Funding $6714611